Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine administration method in knee replacement recovery
ChiCTR1900025808Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in knee osteoarthritis (OA) (3 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Duration of analgesia: time to first report pain. Started Mar 2020; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR1900025808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025808.